Zai Lab (ZLAB) Amortization of Deferred Charges (2018 - 2026)

Zai Lab (ZLAB) posted quarterly Amortization of Deferred Charges of -$1.4 million for Q1 2026, down 4.66% year-on-year from -$1.5 million in Q1 2025, and down 3.26% on a QoQ basis from -$1.3 million in Q4 2025.

Zai Lab (ZLAB) Amortization of Deferred Charges (2018 - 2026) Analysis & Trends

Zai Lab (ZLAB) has reported Amortization of Deferred Charges for 9 consecutive years, with -$1.4 million the latest figure, recorded in Q1 2026.

  • Quarterly Amortization of Deferred Charges fell 4.66% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.4 million (down 34.68% YoY) and the FY2025 annual result came in at -$5.3 million, down 51.7% from the prior year.
  • Amortization of Deferred Charges declined to -$1.4 million in Q1 2026 per ZLAB's latest filing, from -$1.3 million in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for ZLAB reached as high as -$561000.0 in Q4 2022 and fell as low as -$1.4 million in Q1 2026.
  • A 5-year average of -$955176.5 and a median of -$839000.0 in 2024 frame the typical range for Amortization of Deferred Charges.
  • Annual changes were most pronounced in 2022 — Amortization of Deferred Charges slumped 807.69% — and 2024, when it increased 26.01%.
  • Year by year, Amortization of Deferred Charges stood at -$561000.0 in 2022, then tumbled by 49.02% to -$836000.0 in 2023, then slipped by 19.86% to -$1.0 million in 2024, then slumped by 34.63% to -$1.3 million in 2025, then dropped by 3.26% to -$1.4 million in 2026.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods registered -$1.4 million, -$1.3 million, and -$1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,011.97 Bn 67,011.68 Bn -
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 471.88 Bn 467.08 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.20 Bn 114.96 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.93 Bn 61.17 Bn 3.31 Bn
7 Belite Bio 62.34 Bn 62.34 Bn -
8 Argenx Se 55.85 Bn 50.67 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.50 Bn 34.49 Bn 959.66 Mn
10 Zai Lab 20.57 Bn 19.82 Bn 61.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.39 Mn
Mar 31, 2026 -1.39 Mn
Dec 31, 2025 -1.35 Mn
Dec 31, 2025 -1.35 Mn
Sep 30, 2025 -1.33 Mn
Sep 30, 2025 -1.33 Mn
Jun 30, 2025 -1.33 Mn
Jun 30, 2025 -1.33 Mn
Mar 31, 2025 -1.33 Mn
Mar 31, 2025 -1.33 Mn
Dec 31, 2024 -1.00 Mn
Dec 31, 2024 -1.00 Mn
Sep 30, 2024 -839,000.00
Sep 30, 2024 -839,000.00
Jun 30, 2024 -839,000.00
Jun 30, 2024 -839,000.00
Mar 31, 2024 -840,000.00
Mar 31, 2024 -840,000.00
Dec 31, 2023 -836,000.00
Dec 31, 2023 -836,000.00